Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord plasma for endometrial regeneration in endometrial pathology
2020-005717-40Phase 2Active
- Sponsor
- IVI Foundation
- Start
- Feb 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of umbilical cord-derived platelet-rich plasma in Endometrial hypotrophy, Intrauterine Adhesions (IUA) and Atrophic endometrium, sponsored by IVI Foundation. Started Feb 2021; status: active.
02
Drugs
umbilical cord-derived platelet-rich plasma
03
Conditions
Endometrial hypotrophyIntrauterine Adhesions (IUA)Atrophic endometrium
Beyond the preview
Go deeper on 2020-005717-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005717-40.